期刊文献+

二溴青酶烷砜酸脱溴制备舒巴坦的工艺研究

Technical Investigation on the Synthesis of Sulbactam by Debrominating Dibromosulbactam Acid
下载PDF
导出
摘要 本文对以6-APA为原料制备舒巴坦的关键工艺过程——脱溴还原工艺过程的方法选择和优化进行了研究,分别对以锌、镁为还原剂工艺和以镍、钯碳为催化剂的氢气还原工艺进行了比较和研究,得出以钯碳为催化剂,在0.2MPa下,以氢气为还原剂对二溴青酶烷砜酸进行脱溴还原工艺具有比较明显的优势,制得β-内酰胺酶抑制剂——舒巴坦的收率可达到86.5%。 In this article, the method and optimization of the debromination-reduction technical process were investigated which was the key step in the synthesis of sulbactam with 6-Aminopenicillanic acid material. Respectively compared the reductive process when Zn, Mg was used as reductant and Ni, Pd (C) as catalyst under hydrogen atmosphere, the debromination-reduction technical process provided obvious advantage and the yield of β-lactamase inhibitor sulbactam could reach 86.5% in the present of Pd(C) catalyst and hydrogen at the pressure of 0.2 MPa.
作者 刘莹
出处 《化工中间体》 2006年第7期26-28,共3页
关键词 舒巴坦 钯碳催化剂 还原 6-APA Sulbactam Pd(C) catalyst Reduction 6-APA
  • 相关文献

参考文献11

  • 1程宏辉,谢朝晖.舒巴坦钠合成工艺的研究[J].化工设计通讯,2001,27(2):61-62. 被引量:12
  • 2宋智梅,刘巍巍,杨静,孙元珍.舒巴坦的生产工艺改进[J].中国药物化学杂志,2004,14(3):180-181. 被引量:5
  • 3Domingo Blanco Gomis;No é S á nchez;Elena Andr é s Garc í a;Miguel Bayod Jasanada M.Dolores Guti é rrez Alvarez.Fast high performance liquid chromatography method for in-process control of sulbactam,2003(1-2).
  • 4Pfizer Inc.7-(D-2-[ethylpierazine-2,3-dione-1-carbox-amido]-2-[4-hydroxypheny]acetamido)-3-([1-methyl-5-tetrazolyl]thiomerthyl)-3 -deacetoxymethylcephalosporanic acid and penicillanic acid 1,1-dioxide and pharmaceutical composition containing them,1980.
  • 5Irena P Kostova;Lubomir S Changov;Emma E Keuleyan.Synthesis,analysis and in vitro antibacterial activity of new metal complexes of sulbactam,1999(12).
  • 6Suren husinec;Deana Dragovic.SOME APPROACHES TO THE SYNTHESIS OF SULBACTAM,1989.
  • 7任升俊;李正化.青霉烷砜酸的合成,1984(02).
  • 8白国义,马桂秋,侯曼玲,李阳,曹琳,王丰雷.β-内酰胺酶抑制剂的研究进展[J].化学工业与工程,2001,18(6):395-400. 被引量:10
  • 9Barth WE.6-Substituted penieillanie acid 1,1-dioxide compounds,1984.
  • 10游金莺;欧阳凯.B-内酰胺酶抑制剂一CP45899的工艺研究,1986(04).

二级参考文献11

  • 1张建民,钟超平.泰唑巴坦合成路线图解[J].中国医药工业杂志,1995,26(9):428-429. 被引量:7
  • 2张致平.20世纪90年代β-内酰胺类抗生素研究开发的进展[J].国外医药(抗生素分册),1996,17(1):1-18. 被引量:12
  • 3陈冠荣 时钧 等.化工百科全书,第1版[M].北京:化学工业出版社,1995..
  • 4Pfizer Inc.7-(D-2-[ethylpiperazine-2,3-dione-1-carboxamido]-2-[4-hydroxyphenyl]acetamido)-3-([1-methyl-5-tetrazolyl]thiomethyl)-3-deacetoxymethylcephalosporanic acid and penicillanic acid 1,1-dioxide and pharmaceutical composition containing them[P].FR:24
  • 5Volkmann RA,Moore BS,Carroll RD,et al.Efficient preparation of 6,6-dihalopenicillanic acids,synthesis of penicillanic acid S,S-dioxide(sulbactam)[J].J Org Chem,1982,47(17):3344-3345.
  • 6Moore BS,Carroll RD,Volkmann RA.Penicillanic acid 1,1-dioxide and its ester and intermediate[P].US:4420426,1979-05-05.
  • 7Barth WE.6-Substituted penicillanic acid 1,1-dioxide compounds[P].US:4590073,1984-10-22.
  • 8任升俊 李正化.青霉烷砜酸的合成[J].医药工业杂志,1984,139(2):1-3.
  • 9游金莺 欧阳凯.β—内酰胺酶抑制剂—CP45899的工艺研究[J].中国抗生素杂志,1986,11(4):363-365.
  • 10张永龙,李家泰.β-内酰胺酶抑制剂tazobactam与舒巴坦的比较研究[J].中国抗生素杂志,1997,22(4):287-293. 被引量:35

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部